Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Artesunate for Injection for the Treatment of Severe Malaria

Drug Name

Artesunate for Injection

Developer

US Army Medical Research and Development Command and Amivas

Therapy Class

Antimalarial

Current Indication

Severe malaria

Market Class

Infectious diseases

Development Class

Approved in the US
Expand
Close
Close
Close

Go Top